BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

Labcorp Launches First FDA Cleared Rapid Fentanyl Urine Test Made In The United States

First FDA-cleared rapid fentanyl test of its kind made in the United States designed to help emergency department and hospital teams ...

April 20, 2026 | News

Waters Secures IVDR CE Mark For BD BACTEC FXI System Advancing Faster Bloodstream Infection Diagnostics

Achieves a ~3‑hour faster time to detection (~15% reduction) versus the prior generation system, per clinical study data,¹ enabling earlier target...

April 20, 2026 | News

Perceptive Discovery Partners MH3D To Launch α Sight Imaging For Alpha Radiopharmaceuticals

Perceptive Discovery announced a strategic partnership with MH3D alongside the launch of α-Sight™, a new preclinical imaging offering enabling ...

April 17, 2026 | News

Mabwell Secures NMPA IND Acceptance For First In Class LILRB4 CD3 Bispecific Antibod

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the National Medical Products Ad...

April 17, 2026 | News

Haisco Partners With AbbVie To Advance Global Pain Therapeutics Pipeline

Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with AbbVie (NYSE: ABBV), a...

April 14, 2026 | News

Miracell Secures U.S. FDA Clearance For SMART M Cell System Advancing Regenerative Therapies

Blood- and bone marrow-based efficient growth factors extraction system demonstrates substantial equivalence and high cell viability Miracell, a...

April 13, 2026 | News

Thermo Fisher Scientific Partners PRECISE To Advance Singapore’s Landmark SG100K Biobank Study

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with Precision Health Research, S...

April 10, 2026 | News

Lumonus And Memorial Sloan Kettering Cancer Center Collaborate To Scale Automated Radiation Therapy Planning

Lumonus, the company behind Lumonus AI, a platform for radiation oncology clinical workflow and automated treatment planning, announced a collaboration wit...

April 09, 2026 | News

Neurocrine Biosciences To Acquire Soleno Therapeutics For $2.9 Billion To Strengthen Rare Disease Portfolio

VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and...

April 07, 2026 | News

Syneron Bio Secures Series B Financing To Advance Macrocyclic Peptide Discovery Platform And Clinical Pipeline

Syneron Bio, a leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on Marc...

April 06, 2026 | News

Roche Secures FDA Clearance For Cobas c 703 And Cobas ISE Neo Analytical Units

The cobas® c 703 and cobas® ISE neo analytical units deliver higher testing capacity and increased automation, helping to improve laboratory work...

April 01, 2026 | News

Aroa Biosurgery Reports Positive Primary Endpoint Achievement In Symphony RCT For Diabetic Foot Ulcers

Aroa Biosurgery Limited announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the...

March 31, 2026 | News

AstraZeneca Reports Positive Phase 3 Results For Tozorakimab In COPD

Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease (COPD) showed that tozoraki...

March 30, 2026 | News

Bioptimus Launches STELA Initiative To Build World’s Largest Multimodal Atlas For AI Driven Biology

The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale...

March 27, 2026 | News

Stay Connected